エピソード

  • Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research

    Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
    2025/04/14
    LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, discusses strategies to address underrepresentation in phase III psoriasis trials. She also talks about Takeda's partnerships with community stakeholders like Inside Edge, Black Health Matters, and Hispanic Communication Global Network to help improve engagement, address operational barriers by incorporating multicultural imagery, and prioritize sites with diverse patient demographics. She also explains how they've enhanced investigator diversity through educational sessions and multilingual toolkits, and how Takeda aims to expand these efforts globally.
    続きを読む 一部表示
    17 分
  • Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals

    Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
    2025/03/24
    In this Pharmaceutical Executive podcast epsiode, Peter Ax, Founder & CEO of UpScriptHealth, discusses:
    • The impact of tariffs on the pharmaceutical industry, highlighting branded and generics medications
    • How tariffs could lead to strategic supply chain changes, including potential US manufacturing shifts.
    • How digital health platforms, like UpScriptHealth, can help reduce friction and costs in healthcare, potentially offsetting tariff impacts
    • The importance of telehealth in ensuring medication availability
    • Strategic partnerships between digital health platforms and pharma companies to improve patient care and access
    • and more
    続きを読む 一部表示
    18 分
  • The Misinformation Maze: Navigating Public Health in the Digital Age

    The Misinformation Maze: Navigating Public Health in the Digital Age
    2025/03/11
    In this episode of the Pharmaceutical Executive podcast, Jennifer Butler, Chief Commercial Officer of Pleio, discusses:
    • The threat of misinformation to public health and how emotional appeal plays a part
    • Where patients are turning for trustworthy health information
    • Strategies that can be used to verify information
    • Pharma's role in helping to ensure patients have access to health insights they can trust
    • Why the industry is turning to peer-to-patient platforms, trusted patient communities, and pharmacies to educate patients
    • What kind of role regulatory agencies should play in the battle against misinformation
    • and much more!
    Check out our new look and read our February issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-february-2025
    続きを読む 一部表示
    24 分
  • Navigating Distrust: Pharma in the Age of Social Media

    Navigating Distrust: Pharma in the Age of Social Media
    2025/02/18
    In this episode of the Pharmaceutical Executive Podcast, CEO and Founder of Sooth, Ian Baer, is back to discuss:
    • The growing distrust in social media
    • Why people trust friends and influencers over companies
    • The EMA's departure from X
    • Concerns about information accessibility
    • The healthcare industry's trust gap
    • "Dark Social"
    • and SO MUCH MORE!
    Pharmaceutical Executive has a brand new look! Click through our February issue here: https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-february-2025
    続きを読む 一部表示
    27 分
  • Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement

    Revolutionizing Patient Adherence: Leveraging AI for Personalized Engagement
    2025/02/10
    In this episode of the Pharmaceutical Executive podcast, Bill Grambley, CEO of AllazoHealth, delves into the potential of AI to revolutionize patient engagement and adherence. By utilizing patient-level data and predictive modeling, AI can identify individual needs and preferences, tailoring interventions to optimize treatment outcomes. This personalized approach addresses the common challenges of medication non-adherence and improves patient outcomes. The discussion highlights the importance of ethical considerations and data privacy when leveraging AI in healthcare. By focusing on patient well-being and using AI responsibly, healthcare providers can significantly enhance patient experiences and improve overall health outcomes.
    続きを読む 一部表示
    19 分
  • The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations

    The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
    2025/01/30
    In this episode of the Pharmaceutical Executive podcast, Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses the challenges of addressing fertility misinformation on social media. He emphasizes the importance of providing accurate and reliable information and encourages patients to consult with healthcare professionals. He also discusses the ethical considerations of using social media to share personal and professional experiences in the field of fertility and so much more!
    続きを読む 一部表示
    30 分
  • Key Findings of the NIAGARA and HIMALAYA Trials

    Key Findings of the NIAGARA and HIMALAYA Trials
    2024/11/08
    In this episode of the Pharmaceutical Executive podcast, Shubh Goel, Head of Immuno-Oncology and Gastrointestinal Tumors, US Oncology Business Unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer, and much more.
    続きを読む 一部表示
    13 分
  • Fake Weight Loss Drugs: Growing Threat to Consumer Health

    Fake Weight Loss Drugs: Growing Threat to Consumer Health
    2024/10/25
    UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss:
    • Counterfeit weight loss drugs (particularly fake Ozempic) and potential health risks
    • What can be done to raise awareness among consumers about the dangers of counterfeit medications
    • Ways increase access to legitimate weight loss medications, especially for those in underserved communities
    • and much more!
    続きを読む 一部表示
    21 分